{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:56:13Z","timestamp":1788216973880,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Womens Ment Health"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00737-024-01540-3","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T21:47:19Z","timestamp":1734904039000},"page":"911-918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of congenital anomalies associated with psychotropic medications: a review of neonatal reports in the FDA adverse event reporting System (FAERS)"],"prefix":"10.1007","volume":"28","author":[{"given":"Jingping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yankun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chufeng","family":"Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0594-9181","authenticated-orcid":false,"given":"Ling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"1540_CR1","doi-asserted-by":"publisher","unstructured":"Andrade C (2021) Major Congenital Malformations Associated with exposure to second-generation antipsychotic drugs during pregnancy. J Clin Psychiatry, 82(5).\u00a0https:\/\/doi.org\/10.4088\/jcp.21f14252","DOI":"10.4088\/jcp.21f14252"},{"issue":"5","key":"1540_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1517\/14740338.2016.1167184","volume":"15","author":"PS Ang","year":"2016","unstructured":"Ang PS et al (2016) Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures. Expert Opin Drug Saf 15(5):583\u2013590","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"1540_CR3","doi-asserted-by":"publisher","first-page":"e1003851","DOI":"10.1371\/journal.pmed.1003851","volume":"18","author":"MZ Ankarfeldt","year":"2021","unstructured":"Ankarfeldt MZ et al (2021) Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: a nationwide cohort study in Denmark and Sweden. PLoS Med 18(11):e1003851","journal-title":"PLoS Med"},{"issue":"1","key":"1540_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40801-022-00334-2","volume":"10","author":"MZ Ankarfeldt","year":"2023","unstructured":"Ankarfeldt MZ et al (2023) Duloxetine exposure during pregnancy and the risk of offspring being born small for gestational age or prematurely: a nationwide Danish and Swedish safety study. Drugs Real World Outcomes 10(1):69\u201381","journal-title":"Drugs Real World Outcomes"},{"key":"1540_CR5","doi-asserted-by":"crossref","unstructured":"Li J, Fei X, Wang S, Xu Z, Xu F, Wang J, Gao Y, Hu Y. (2024) A bibliometric analysis of the WoSCC literature on the use of selective serotonin reuptake inhibitors as antidepressants. Drug Des Devel Ther 18:4961\u20134974","DOI":"10.2147\/DDDT.S476680"},{"issue":"3","key":"1540_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/0167482X.2017.1321632","volume":"39","author":"PS Ertekin","year":"2018","unstructured":"Ertekin PS et al (2018) Effect of stress management training on depression, stress and coping strategies in pregnant women: a randomised controlled trial. J Psychosom Obstet Gynaecol 39(3):203\u2013210","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"4","key":"1540_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000491524","volume":"87","author":"GA Fava","year":"2018","unstructured":"Fava GA et al (2018) Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom 87(4):195\u2013203","journal-title":"Psychother Psychosom"},{"issue":"5","key":"1540_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1891\/11-T-704","volume":"40","author":"K Fons","year":"2021","unstructured":"Fons K, Jnah AJ, Malformation A-C (2021) Arnold-Chiari malformation: core concepts. Neonatal Netw 40(5):313\u2013320","journal-title":"Neonatal Netw"},{"issue":"1","key":"1540_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12916-018-1193-5","volume":"16","author":"SY Gao","year":"2018","unstructured":"Gao SY et al (2018) Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med 16(1):205","journal-title":"BMC Med"},{"issue":"1","key":"1540_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s11689-024-09577-2","volume":"16","author":"TH Han","year":"2024","unstructured":"Han TH, Chae KY, Han B, Kim JH, Ha EK, Rhie S, Han MY (2024) Early onset and increasing disparities in neurodevelopmental delays from birth to age 6 in children from low socioeconomic backgrounds. J Neurodev Disord 16(1):60","journal-title":"J Neurodev Disord"},{"issue":"2","key":"1540_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ejpn.2016.11.003","volume":"21","author":"J Holland","year":"2017","unstructured":"Holland J, Brown R (2017) Neonatal venlafaxine discontinuation syndrome: a mini-review. Eur J Paediatr Neurol 21(2):264\u2013268","journal-title":"Eur J Paediatr Neurol"},{"key":"1540_CR12","doi-asserted-by":"publisher","first-page":"m237","DOI":"10.1136\/bmj.m237","volume":"368","author":"KF Huybrechts","year":"2020","unstructured":"Huybrechts KF et al (2020) Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ 368:m237","journal-title":"BMJ"},{"issue":"9","key":"1540_CR13","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jamapsychiatry.2016.1520","volume":"73","author":"KF Huybrechts","year":"2016","unstructured":"Huybrechts KF et al (2016) Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry 73(9):938\u2013946","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"1540_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jamapsychiatry.2022.4109","volume":"80","author":"KF Huybrechts","year":"2023","unstructured":"Huybrechts KF et al (2023) Association of in Utero antipsychotic medication exposure with risk of congenital malformations in nordic countries and the US. JAMA Psychiatry 80(2):156\u2013166","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"1540_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.nec.2015.06.005","volume":"26","author":"MP Kelly","year":"2015","unstructured":"Kelly MP, Guillaume TJ, Lenke LG (2015) Spinal deformity Associated with Chiari Malformation. Neurosurg Clin N Am 26(4):579\u2013585","journal-title":"Neurosurg Clin N Am"},{"issue":"9","key":"1540_CR16","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1517\/14656566.2015.1041501","volume":"16","author":"J Kulkarni","year":"2015","unstructured":"Kulkarni J et al (2015) Antipsychotic use in pregnancy. Expert Opin Pharmacother 16(9):1335\u20131345","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"1540_CR17","doi-asserted-by":"publisher","first-page":"100950","DOI":"10.1016\/j.ajogmf.2023.100950","volume":"5","author":"X Liu","year":"2023","unstructured":"Liu X et al (2023) Maternal antipsychotic use during pregnancy and congenital malformations. Am J Obstet Gynecol MFM 5(6):100950","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"11","key":"1540_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/phar.2628","volume":"41","author":"C Marks","year":"2021","unstructured":"Marks C et al (2021) Comparing newborn outcomes after prenatal exposure to individual antidepressants: a retrospective cohort study. Pharmacotherapy 41(11):907\u2013914","journal-title":"Pharmacotherapy"},{"issue":"5","key":"1540_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/0269881117699361","volume":"31","author":"RH McAllister-Williams","year":"2017","unstructured":"McAllister-Williams RH et al (2017) British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 31(5):519\u2013552","journal-title":"J Psychopharmacol"},{"issue":"2","key":"1540_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2850.2009.01481.x","volume":"17","author":"K McCauley-Elsom","year":"2010","unstructured":"McCauley-Elsom K et al (2010) Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs 17(2):97\u2013104","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"1540_CR21","doi-asserted-by":"publisher","first-page":"103521","DOI":"10.1016\/j.midw.2022.103521","volume":"116","author":"F Monteiro","year":"2023","unstructured":"Monteiro F et al (2023) Exploring factors associated with complete mental health of pregnant women during the COVID-19 pandemic. Midwifery 116:103521","journal-title":"Midwifery"},{"issue":"6","key":"1540_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/acps.13431","volume":"145","author":"A Ostenfeld","year":"2022","unstructured":"Ostenfeld A et al (2022) Mirtazapine exposure in pregnancy and fetal safety: a nationwide cohort study. Acta Psychiatr Scand 145(6):557\u2013567","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"1540_CR23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T et al (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10(7):796\u2013803","journal-title":"Int J Med Sci"},{"issue":"4","key":"1540_CR24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.reprotox.2011.09.004","volume":"32","author":"TW Sadler","year":"2011","unstructured":"Sadler TW (2011) Selective serotonin reuptake inhibitors (SSRIs) and heart defects: potential mechanisms for the observed associations. Reprod Toxicol 32(4):484\u2013489","journal-title":"Reprod Toxicol"},{"issue":"2","key":"1540_CR25","first-page":"e1059","volume":"9","author":"H Sagreiya","year":"2017","unstructured":"Sagreiya H et al (2017) Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and geriatric populations. Cureus 9(2):e1059","journal-title":"Cureus"},{"key":"1540_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajp.2019.08.016","volume":"45","author":"MU Shad","year":"2019","unstructured":"Shad MU et al (2019) How to identify and manage non-response to clozapine? Asian J Psychiatr 45:50\u201352","journal-title":"Asian J Psychiatr"},{"issue":"2","key":"1540_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/JCP.0000000000000279","volume":"35","author":"M Smit","year":"2015","unstructured":"Smit M et al (2015) Mirtazapine in pregnancy and lactation: data from a case series. J Clin Psychopharmacol 35(2):163\u2013167","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"1540_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.euroneuro.2015.06.014","volume":"26","author":"M Smit","year":"2016","unstructured":"Smit M, Dolman KM, Honig A (2016) Mirtazapine in pregnancy and lactation - A systematic review. Eur Neuropsychopharmacol 26(1):126\u2013135","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"1540_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/jamainternmed.2022.0375","volume":"182","author":"L Straub","year":"2022","unstructured":"Straub L et al (2022) Association of Antipsychotic Drug Exposure in pregnancy with risk of Neurodevelopmental disorders: a National Birth Cohort Study. JAMA Intern Med 182(5):522\u2013533","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1540_CR30","doi-asserted-by":"publisher","first-page":"103422","DOI":"10.1016\/j.drudis.2022.103422","volume":"28","author":"G Tan","year":"2023","unstructured":"Tan G et al (2023) Drug repurposing using real-world data. Drug Discov Today 28(1):103422","journal-title":"Drug Discov Today"},{"key":"1540_CR31","doi-asserted-by":"publisher","unstructured":"Watanabe N et al (2011) Mirtazapine versus other antidepressive agents for depression. Cochrane Database Syst Rev (12):CD006528.\u00a0https:\/\/doi.org\/10.1002\/14651858.cd006528.pub2","DOI":"10.1002\/14651858.cd006528.pub2"},{"issue":"5","key":"1540_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000516031","volume":"90","author":"J Wang","year":"2021","unstructured":"Wang J, Cosci F (2021) Neonatal Withdrawal Syndrome following late in utero exposure to selective serotonin reuptake inhibitors: a systematic review and Meta-analysis of Observational studies. Psychother Psychosom 90(5):299\u2013307","journal-title":"Psychother Psychosom"},{"issue":"3","key":"1540_CR33","doi-asserted-by":"publisher","first-page":"100384","DOI":"10.1016\/j.xagr.2024.100384","volume":"4","author":"A White","year":"2024","unstructured":"White A, Afsari M, Balakrishnan H, Chapa E, Kim M, Mehra S, Faucher MA, Miller J, Cordova P, Duryea EL, Nelson DB, Ambia AM, Mcintire DD, Adhikari EH (2024) Implementation of universal screening for substance use in pregnancy in a public healthcare system. AJOG Glob Rep 4(3):100384","journal-title":"AJOG Glob Rep"},{"key":"1540_CR34","doi-asserted-by":"publisher","first-page":"1393115","DOI":"10.3389\/fmed.2024.1393115","volume":"11","author":"J Xue","year":"2024","unstructured":"Xue J, Xue J, Ru Y, Zhang G, Yin H, Liu D (2024) Ultrasound assessment of insular development in adequate-for-gestational-age fetuses and fetuses with early-onset fetal growth restriction using 3D-ICRV technology. Front Med (Lausanne) 11:1393115","journal-title":"Front Med (Lausanne)"}],"container-title":["Archives of Women's Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-024-01540-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00737-024-01540-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00737-024-01540-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:02:16Z","timestamp":1757721736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00737-024-01540-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1007\/s00737-024-01540-3","relation":{},"ISSN":["1434-1816","1435-1102"],"issn-type":[{"value":"1434-1816","type":"print"},{"value":"1435-1102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}